Balchem BCPC Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $72.87M-2.3% | $74.57M+14.6% | $65.09M-0.5% | $65.43M+31.1% | $49.9M+0.8% | ||
| $154.23M+7.4% | $143.6M+9.2% | $131.54M-3.3% | $135.98M+4.2% | $130.45M+9.0% | ||
| $146.74M+11.6% | $131.45M-0.7% | $132.44M-10.6% | $148.15M+2.2% | $144.93M+10.8% | ||
| $388.94M+6.4% | $365.61M+6.4% | $343.72M-5.8% | $364.86M+7.2% | $340.24M+8.4% | ||
| $303.07M-1.2% | $306.65M+3.0% | $297.84M+2.7% | $290.09M+2.2% | $283.75M+0.6% | ||
| $811.45M-0.6% | $816.38M0.0% | $816.49M0.0% | $816.39M+2.9% | $793.09M+1.7% | ||
| $28.78M-5.0% | $30.3M-3.3% | $31.33M-3.7% | $32.52M-80.4% | $165.97M+410% | ||
| $1.69B+0.4% | $1.69B+1.5% | $1.66B-1.0% | $1.68B+3.8% | $1.62B+2.7% | ||
| $70.73M+17.1% | $60.43M+28.6% | $46.98M-30.8% | $67.86M+2.9% | $65.98M+20.5% | ||
| $207K+1.0% | $205K+1.5% | $202K+1.5% | $199K+1.0% | $197K+1.5% | ||
| $152.54M-13.5% | $176.38M+39.6% | $126.37M-8.5% | $138.14M-1.0% | $139.56M-11.5% | ||
| $21.65M+0.9% | $21.44M+0.5% | $21.34M+3.5% | $20.62M+3.4% | $19.94M+3.1% | ||
| $408.63M-4.7% | $428.84M+18.1% | $363.17M-11.5% | $410.33M+0.4% | $408.85M-3.9% | ||
| 120M0.0% | 120M0.0% | 120M0.0% | 120M0.0% | 120M+5,430% | ||
| $1.16B+3.6% | $1.12B+0.7% | $1.11B+3.8% | $1.07B+3.7% | $1.03B+3.7% | ||
| $1.29B+2.2% | $1.26B-3.1% | $1.3B+2.4% | $1.27B+4.9% | $1.21B+5.1% | ||
| $1.69B+0.4% | $1.69B+1.5% | $1.66B-1.0% | $1.68B+3.8% | $1.62B+2.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Balchem cover its short-term obligations?
- Its current ratio is 2.55 — current assets exceed current liabilities.
- Where does Balchem's balance sheet data come from?
- Every line is extracted from Balchem's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.